Mary‐Kate Malecek

Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions

Victor M. Orellana‐Noia, Daniel Reed, Ashley McCook et al. · Blood · 2021 · 91 citations · Full text

Statins as anti-cancer therapy; Can we translate preclinical and epidemiologic data into clinical benefit?

Young Kwang Chae, Muhammad Yousaf, Mary‐Kate Malecek et al. · PubMed · 2015 · 46 citations

Pathology, Anti-cancer Therapy, Statin Use +21

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

David A. Bond, Jeffrey M. Switchenko, Diego Villa et al. · Blood Advances · 2021 · 38 citations · Full text

Disease Progression, Prognosis, Pathology +17

Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma

Victor M. Orellana‐Noia, Krista M. Isaac, Mary‐Kate Malecek et al. · Blood Advances · 2021 · 29 citations · Full text

Aging, Cancer Management, Prognosis +18

Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 <scp>U.S.</scp> cancer centers

Kevin A. David, Suchitra Sundaram, Seo‐Hyun Kim et al. · American Journal of Hematology · 2023 · 24 citations · Full text

Hematological Malignancy, Neuro-oncology, Lymphoid Neoplasia +14